Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma

ClinicalTrials.gov ID: NCT02014142

Public ClinicalTrials.gov record NCT02014142. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Single-Masked, Randomized Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Determine efficacy of the latanoprost punctal plug. Effect of configuration of L-PPDS placement on efficacy will also be examined.

Study identification

NCT ID
NCT02014142
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mati Therapeutics Inc.
Industry
Enrollment
86 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2013 (Type not available)
Primary completion
Dec 2016 (Actual)
Completion
Dec 2016 (Actual)
Last update posted
Jan 18, 2017

2013 – 2016

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
18
Facility City State ZIP Site status
Arizona Eye Center Chandler Arizona 85225 —
Arizona Glaucoma Specialists Phoenix Arizona 85050 —
Wolstan & Goldberg Eye Associates Torrance California 90505 —
Argus Research at Cape Coral Eye Center Cape Coral Florida 33904 —
Eye Associates of Fort Myers Fort Myers Florida 33901 —
Indiana Universtiy - Eugene and Marilyn Glick Eye Institute Ophthalmology Center Indianapolis Indiana 46202 —
Cincinnati Eye Institute Edgewood Kentucky 41017 —
Great Lakes Eye Care Saint Joseph Michigan 49085 —
Chu Vision Institute Bloomington Minnesota 55420 —
Ophthalmology Associates St Louis Missouri 63131 —
Comprehensive Eye Care, Ltd. Washington Missouri 63090 —
Abrams Eye Institute Las Vegas Nevada 89148 —
Ophthalmic Consultants of Long Island Lynbrook New York 11563 —
Dr. Steven T. Simmons Slingerlands New York 12159 —
Philadelphia Eye Associates Philadelphia Pennsylvania 19148 —
Wills Eye Hospital Phildelphia Pennsylvania 19107 —
University Eye Surgeons Maryville Tennessee 37803 —
Total Eye Care Memphis Tennessee 38119 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02014142, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2017 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02014142 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →